Published on Mar 8, 2024 Share
Akadeum Life Sciences has joined forces with Agilent to combat the spread of infectious diseases through innovative wastewater testing kits. Highlighted in a recent Patient Safety & Quality Healthcare publication, this collaboration will revolutionize public health surveillance, providing a faster, simpler, and more efficient alternative to traditional methods when extracting important diagnostic markers from wastewater samples. The new Viral DNA-RNA Wastewater Prep Kit leverages microbubbles to extract nucleic acids gently …
Published on Feb 14, 2024 Share
The additions of Jeff Williams and Brett Williams will reinforce Akadeum’s strategic expansion and drive commercial growth in the cell separation and life sciences industry. Ann Arbor, MI, February 14, 2024 – Akadeum Life Sciences, the global leader in buoyancy-based cell separation, has today announced the appointment of Jeff Williams as Executive Chairman of the board and Brett Williams as a Director of the board. Jeff and Brett will play …
Published on Feb 13, 2024 Share
“Our dedication to thorough research and our commitment to listening to the voice of the customer has resulted in a truly outstanding innovation.” Akadeum Life Sciences was recently featured as a Top 10 BioTech Startup of 2023 by PharmaTech Outlook magazine. In recognition of the award, PharmaTech Outlook published an article highlighting the innovative work happening at Akadeum to reignite the stagnant cell separation market. Akadeum’s microbubble technology overcomes the …
Published on Jan 17, 2024 Share
The Human T Cell Selection, Activation, and Expansion and Human T Cell Depletion kits use Akadeum’s BACS™ microbubbles to streamline cell therapy workflows. ANN ARBOR, MI, Jan 16, 2024 – Today, Akadeum Life Sciences, the market leader in buoyancy-based cell separation is announcing the release of a Human T Cell Selection, Activation, and Expansion Kit (GMP Grade), and a Human T Cell Depletion Kit (GMP Grade) at the Advanced Therapies …
Published on Jan 9, 2024 Share
Partnership uses Akadeum’s revolutionary microbubble technology for viral processing. ANN ARBOR, Michigan, Jan. 5, 2024 – Akadeum Life Sciences, Inc., announced today an innovative solution for the detection of viral DNA/RNA in wastewater, developed from a collaboration with Agilent Technologies, Inc. which started in October 2019. Wastewater surveillance monitoring has become an important method for mass screening of communities, offering an early warning system for emerging infectious diseases like SARS-CoV-2. …
Published on Jan 8, 2024 Share
With products that gently isolate and activate cells, Akadeum’s founder and CEO will discuss the impact the company is having on the cell and gene therapy space. ANN ARBOR, MI, Jan. 8, 2024 – Akadeum Life Sciences—the global leader in buoyancy-based cell separation technology—has been selected to present on its revolutionary microbubble platform at this year’s Biotech Showcase, which is being held from January 8-10 in San Francisco. Brandon McNaughton, …
Published on Jan 3, 2024 Share
Brandon McNaughton, CEO of Akadeum Life Sciences Inc., recently shared insights with BioWorld about the company’s Alerion™ Microbubble Cell Separation System, set to transform cell therapy. Akadeum, established in 2014, has developed a unique microbubble-based cell separation technology. The Alerion™ Microbubble Cell Separation System promises to overcome the limitations of existing methods, offering better workflows, scalability, and productivity. The Alerion™ system uses a two-chamber consumable, allowing microbubbles to adhere to …
Published on Jan 2, 2024 Share
Akadeum Life Sciences CEO and Co-Founder Brandon McNaughton‘s recent article, “Microbubbles: The Unlikely Key to Providing Accessible and Effective Cancer Treatments,” has been published by Onco’Zine. Onco’Zine informs and supports healthcare professionals, academics, and pharmaceutical experts in oncology, covering the latest research and developments in the field. McNaughton discusses how Akadeum’s microbubble technology can revolutionize T cell isolation, reducing costs and improving the efficacy of cell therapies like CAR T …
Published on Nov 27, 2023 Share
Akadeum Life Sciences CEO and Co-Founder Brandon McNaughton’s article “CAR T Cell Therapy Is Offering Life-lines to Cancer Patients, but Only to Those Who Can Afford It” was recently published by Medical Device News Magazine. Medical Device News Magazine is a US-based publication that aims to inform and educate medical specialists on breaking device news across various specialties, including general surgery, neurosurgery, artificial intelligence, FDA updates, diagnostic modalities, and executive …
Published on Nov 8, 2023 Share
Akadeum Life Sciences CEO and Co-Founder Brandon McNaughton’s article “Opinion: Cell Therapy Cancer Treatments Are Coming. Now to Make Them More Accessible.” was recently published by BioSpace. BioSpace is a tier 1 life sciences trade publication renowned for delivering the latest industry news and expert analysis. Cell and gene therapies like CAR T cell treatment offer immense promise for cancer, but current high costs limit accessibility. Companies aim to reduce …